https://www.facebook.com/groups/longstrawtips/
Printable View
cheers KW, I always appreciate your thoughts. Quarterly will reveal more.
I have a small holding in Circadian Technologies which is up 52% over the past month, with the majority of its shares being owned by funds outside Australia. Plenty of cash and comparison with other opthamology companies with 10-60 times mcap makes interesting reading (p17 - http://www.circadian.com.au/sites/de...%2007%2009.pdf )
AVH First patient treated in US military Wound trial
Cogstate - hitting 40c today, I'm up 30% in the last couple of weeks since buying. Looking like a breakout even though volumes light. Only regret is not buying more.
Hi , Anyone in or been in Compumedics ? (CMP.ax)
There is a recent research report on their investor page
http://www.compumedics.com.au/index....tors-relations
No position currently, but taking a look .
Here keep up will you:mellow::)
Download DocumentAVH appoints ReCell distributors
Download Document AVH extends Recell IP Patent
Download Document CEO invited to present
Download Document Quarterly
Ann: Avita Medical Reports 63% Decreased Length of Hospital Stay
Only 12 patients but very promising.S/P drops ?
Earlier this fall, the U.S. Food and Drug Administration (FDA) approved an expansion of Avita’sCompassionate Use Investigational Device Exemption (IDE) program for ReCellŪ. As part of the expansion,the FDA doubled the patient number to a total of 24 patients who have insufficient healthy skin availablefor standard skin grafting of their injury.
Download Document
FDA'S Grant Avitas Recell Expedited Access Pathway